Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
Elias Zerhouni as the new Chair of its Board of Directors, with Stefan Meister standing down from the Board after six years to focus on his ongoing roles elsewhere. Dr. Zerhouni has been a Board member and Scientific Advisor at Boston Pharmaceuticals since 2021. In assuming the position of Chair, he will now work even more closely with Sophie Kornowski, CEO of Boston Pharmaceuticals, her team, and the community of liver experts as the company's promising drug candidates accelerate their development. In particular, over the past few years Boston Pharmaceuticals has emerged with two exciting candidates in liver diseases and is focused on accelerating BOS-580 , the company's investigational, long-acting, once-monthly fibroblast growth factor 21 (FGF21) analogue for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). "I am pleased to assume the chairmanship of Boston Pharmaceuticals after having been a board member since 2021 and seeing the impressive progress
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients [Yahoo! Finance]Yahoo! Finance
- Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients [Yahoo! Finance]Yahoo! Finance
- OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock [Yahoo! Finance]Yahoo! Finance
OPK
Earnings
- 5/7/24 - Miss
OPK
Sec Filings
- 5/23/24 - Form 4
- 5/17/24 - Form 4
- 5/7/24 - Form 10-Q
- OPK's page on the SEC website